Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22801 AL 22815

Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research

Jung ES, Choi H, Mook-Jung I.

Mol Neurodegener. 2025 Mar 27;20(1):37. doi: 10.1186/s13024-025-00825-0.

Curious Dichotomies of Apolipoprotein E Function in Alzheimer's Disease and Cancer-One Explanatory Mechanism of Inverse Disease Associations?

Perks CM, Barker RM, Alhadrami M, Alkahtani O, Gill E, Grishaw M, Harland AJ, Henley P, Li H, O'Sullivan E, Stone G, Su X, Kehoe PG.

Genes (Basel). 2025 Mar 12;16(3):331. doi: 10.3390/genes16030331.

Neuroprotective Properties of Clove (Syzygium aromaticum): State of the Art and Future Pharmaceutical Applications for Alzheimer's Disease

Sargsyan T, Simonyan HM, Stepanyan L, Tsaturyan A, Vicidomini C, Pastore R, Guerra G, Roviello GN.

Biomolecules. 2025 Mar 20;15(3):452. doi: 10.3390/biom15030452.

The Potential Role of Neurogranin in Alzheimer's Disease

Zhou X, Jing XJ, Zhang H.

J Integr Neurosci. 2025 Mar 20;24(3):25368. doi: 10.31083/JIN25368.

Interconnected Pathways of Alzheimer's Disease and Osteoporosis: A Review of Genetic, Hormonal, and Environmental Influences

Li YX, Liu K, Zeng Q, Zeng WH, Li JL, Zhang QQ, Lu X, Deng HW, Tan LJ.

Aging Dis. 2025 Feb 10;17(1):159-184. doi: 10.14336/AD.2024.1438.

Therapeutic potential and mechanisms of repetitive transcranial magnetic stimulation in Alzheimer's disease: a literature review

Zhang X, Zhu L, Li Y, Yu H, Wang T, Chu X.

Eur J Med Res. 2025 Apr 4;30(1):233. doi: 10.1186/s40001-025-02493-8.

Nrf2/Bach1 signaling axis: A promising multifaceted therapeutic strategy for Alzheimer's disease

Soni P, Sharma SM, Pieper AA, Paul BD, Thomas B.

Neurotherapeutics. 2025 Apr;22(3):e00586. doi: 10.1016/j.neurot.2025.e00586. Epub 2025 Apr 7.

Natural Killer Cells in Alzheimer's Disease: From Foe to Friend

Kostic M, Zivkovic N, Cvetanovic A, Basic J, Stojanovic I.

Eur J Neurosci. 2025 Apr;61(7):e70096. doi: 10.1111/ejn.70096.

Role of saturated fatty acid metabolism in posttranslational modifications of the Tau protein

García-Cruz VM, Coria R, Arias C.

Mol Cell Biochem. 2025 Aug;480(8):4613-4626. doi: 10.1007/s11010-025-05275-2. Epub 2025 Apr 10.

Altered Clearance in Alzheimer's Disease and Cerebral Amyloid Angiopathy

Mohammadi S, Dolatshahi M, Rahmani F, Raji CA.

Neuroimaging Clin N Am. 2025 May;35(2):277-286. doi: 10.1016/j.nic.2024.12.004. Epub 2025 Feb 19.

Reevaluating Alzheimer's disease treatment: Can phytochemicals bridge the therapeutic Gap?

Roy KK, Mehta DK, Das R.

Neuroscience. 2025 May 24;575:1-18. doi: 10.1016/j.neuroscience.2025.04.014. Epub 2025 Apr 10.

Circular RNAs, miRNAs, and Exosomes: Their Roles and Importance in Amyloid-Beta and Tau Pathologies in Alzheimer's Disease

Pala M, Yilmaz SG.

Neural Plast. 2025 Apr 8;2025:9581369. doi: 10.1155/np/9581369. eCollection 2025.

Dynamics and role of covalently-closed circular RNAs in Alzheimer's disease: A review of experimental and bioinformatics studies

Zafarjafarzadeh N, Feridouni E, Sobhani-Moghaddam S, Amini J, Mollazadeh S, Ataei R, Ghomi H, Beyer C, Sanadgol N.

Neurobiol Aging. 2025 Jul;151:54-69. doi: 10.1016/j.neurobiolaging.2025.04.002. Epub 2025 Apr 11.

Biological Effects of Dietary Restriction on Alzheimer's Disease: Experimental and Clinical Investigations

Liu Z, Zhang J, Jiang F, Liu C, Shao Y, Le W.

CNS Neurosci Ther. 2025 Apr;31(4):e70392. doi: 10.1111/cns.70392.

Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil

Alqahtani SM, Al-Kuraishy HM, Al-Gareeb AI, Abdel-Fattah MM, Alsaiari AA, Alruwaili M, Papadakis M, Alexiou A, Batiha GE.

Cell Mol Neurobiol. 2025 Apr 18;45(1):36. doi: 10.1007/s10571-025-01554-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias